Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates

Stopped Insufficient enrollment; departure of primary investigator from institution

Conditions

• Lung Transplant
• Hepatitis B

Interventions

• DRUG: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide

Sponsor

University of Pennsylvania